代谢参数对基于PET/CT的影像组学列线图预测肺腺癌淋巴血管侵犯及结局的附加价值
该回顾性研究纳入272例肺腺癌患者,构建整合临床因素、CT特征和SUVmax的影像组学列线图预测淋巴血管侵犯。CT-RNWS在训练集AUC为0.851、测试集为0.838,训练集中CT-RNWS与CT-RNWOS的AUC差异有统计学意义(P=0.044),病理LVI和SUVmax与预后相关。
要点
- CT形态学是LVI的独立预测因子,SUVmax在训练集和测试集的判别能力均优于CT形态学(P<0.001和P=0.042)。
- CT-RNWS在训练集AUC为0.851、测试集为0.838,训练集中与CT-RNWOS的AUC差异有统计学意义(P=0.044)。
- 病理LVI和SUVmax是PFS的独立预测因子,病理LVI预测的LVI阳性与阴性患者PFS差异有统计学意义(P<0.001)。
核心结论
- 整合Rad-score、临床和PET/CT参数的影像组学列线图对肺腺癌LVI状态显示出良好的预测效能。
- 病理LVI和SUVmax与肺腺癌预后相关。
研究设计与样本
- 回顾性纳入272例接受PET/CT扫描的肺腺癌患者,其中LVI阳性87例、LVI阴性185例。
- 160例SUVmax≥2.5的患者用于PET影像组学分析。
- 提取1409个CT和PET影像组学特征,分别降维至8、8和10个特征构建2D CT-RS、3D CT-RS和PET-RS。
- 构建含Rad-score及独立临床和CT因素、含或不含SUVmax的影像组学列线图(RNWS和RNWOS)。
主要发现
- CT形态学是LVI的独立预测因子。
- SUVmax在训练集(P<0.001)和测试集(P=0.042)的判别能力均优于CT形态学。
- 2D-RS与3D-RS的AUC差异无统计学意义(P>0.05),2D CT-RS的AUC相对高于3D CT-RS。
- CT-RS、CT-RNWOS和CT-RNWS在训练集AUC分别为0.799、0.796和0.851,在测试集AUC分别为0.818、0.822和0.838。
- 训练集中CT-RNWS与CT-RNWOS的AUC差异有统计学意义(P=0.044),DCA示CT-RNWS临床有用性优于CT-RS和CT-RNWOS。
关键数值与推荐
- 训练集中CT-RNWS与CT-RNWOS的AUC差异有统计学意义(P=0.044)。
- DCA示PETCT-RNWS净获益高于PET-RNWS和CT-RNWS。
- 病理LVI预测的LVI阳性与阴性患者PFS差异有统计学意义(P<0.001),RNWS预测的LVI阳性与阴性患者PFS差异有统计学意义(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Lymphovascular invasion (LVI) impairs surgical outcomes in lung adenocarcinoma (LAC) patients. Preoperative prediction of LVI is challenging by using traditional clinical and imaging parameters. The purpose of this study was to investigate the value of the radiomics nomogram integrating clinical factors, CT features, and maximum standardized uptake value (SUVmax) to predict LVI and outcome in LAC and to evaluate the additional value of the SUVmax to the PET/CT-based radiomics nomogram. METHODS: A total of 272 LAC patients (87 LVI-present LACs and 185 LVI-absent LACs) with PET/CT scans were retrospectively enrolled, and 160 patients with SUVmax ≥ 2.5 of them were used for PET radiomics analysis. Clinical data and CT features were analyzed to select independent LVI predictors. The performance of the independent LVI predictors and SUVmax was evaluated. Two-dimensional (2D) and three-dimensional (3D) CT radiomics signatures (RSs) and PET-RS were constructed with the least absolute shrinkage and selection operator algorithm and radiomics scores (Rad-scores) were calculated. The radiomics nomograms, incorporating Rad-score and independent clinical and CT factors, with SUVmax (RNWS) or without SUVmax (RNWOS) were built. The performance of the models was assessed with respect to calibration, discrimination, and clinical usefulness. All the clinical, PET/CT, pathologic, therapeutic, and radiomics parameters were assessed to identify independent predictors of progression-free survival (PFS). RESULTS: CT morphology was the independent LVI predictor. SUVmax provided better discrimination capability compared with CT morphology in the training set (P < 0.001) and test set (P = 0.042). A total of 1409 CT and PET radiomics features were extracted and reduced to 8, 8, and 10 features to build the 2D CT-RS, 3D CT-RS, and the PET-RS, respectively. There was no significant difference in AUC between the 2D-RS and 3D-RS (P > 0.05), and 2D CT-RS showed a relatively higher AUC than 3D CT-RS. The CT-RS, the CT-RNWOS, and the CT-RNWS showed good discrimination in the training set (AUC [area under the curve], 0.799, 0.796, and 0.851, respectively) and the test set (AUC, 0.818, 0.822, and 0.838, respectively). There was significant difference in AUC between the CT-RNWS and CT-RNWOS (P = 0.044) in the training set. Decision curve analysis (DCA) demonstrated the CT-RNWS outperformed the CT-RS and the CT-RNWOS in terms of clinical usefulness. Furthermore, DCA showed the PETCT-RNWS provided the highest net benefit compared with the PET-RNWS and CT-RNWS. PFS was significantly different between the pathologic and RNWS-predicted LVI-present and LVI-absent patients (P < 0.001). Carbohydrate antigen 125 (CA125), carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), pathologic LVI, histologic subtype, and SUVmax were independent predictors of PFS in the 244 CT-RNWS-predicted cohort; and CA125, NSE, pathologic LVI, and SUVmax were the independent predictors of PFS in the 141 PETCT-RNWS-predicted cohort. CONCLUSIONS: The radiomics nomogram, incorporating Rad-score, clinical and PET/CT parameters, shows favorable predictive efficacy for LVI status in LAC. Pathologic LVI and SUVmax are associated with LAC prognosis.
引用
- Nie P, Yang G, Wang N, et al. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma. Eur J Nucl Med Mol Imaging. 2020. PMID: 32451603. doi:10.1007/s00259-020-04747-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。